GLP-1 drugs linked to accelerated bone loss, osteoporosis risk in new five-year analysis – NaturalNews.com
New research analyzing 146,000 patient records found GLP-1 users developed osteoporosis at a 29% higher relative risk than nonusers. A February 2026 study linked GLP-1 drugs to an 11% higher risk of fragility fractures in older adults. Clinical trial